Literature DB >> 22825336

Interferon-gamma enhances radiation-induced cell death via downregulation of Chk1.

Kwang Seok Kim1, Kyu Jin Choi, Sangwoo Bae.   

Abstract

Interferon-gamma (IFNγ) is a cytokine with roles in immune responses as well as in tumor control. Interferon is often used in cancer treatment together with other therapies. Here we report a novel approach to enhancement of cancer cell killing by combined treatment of IFNγ with ionizing radiation. We found that IFNγ treatment alone in HeLa cells induced phosphorylation of Chk1 in a time- and dose-dependent manner, and resulted in cell arrest. Moreover IFNγ treatment was correlated with attenuation of Chk1 as the treatment shortened protein half-life of Chk1. As Chk1 is an essential cell cycle regulator for viability after DNA damage, attenuation of Chk1 by IFNγ pre-treatment in HeLa cells resulted in increased cell death following ionizing radiation about 2-folds than ionizing radiation treatment alone whereas IFNγ treatment alone had little effect on cell death. X-linked inhibitor of apoptosis-associated factor 1 (XAF1), an IFN-induced gene, seems to partly regulate IFNγ-induced Chk1 destabilization and radiation sensitivity because transient depletion of XAF1 by siRNA prevented IFNγ-induced Chk1 attenuation and partly protected cells from IFNγ-enhanced radiation cell killing. Therefore the results provide a novel rationale to combine IFNγ pretreatment and DNA-damaging anti-cancer drugs such as ionizing radiation to enhance cancer cell killing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825336      PMCID: PMC3461808          DOI: 10.4161/cbt.20990

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  36 in total

1.  IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis.

Authors:  A C Hobeika; W Etienne; B A Torres; H M Johnson; P S Subramaniam
Journal:  J Interferon Cytokine Res       Date:  1999-12       Impact factor: 2.607

2.  DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.

Authors:  Olga Moiseeva; Frédérick A Mallette; Utpal K Mukhopadhyay; Adrian Moores; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

3.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

Authors:  Q Liu; S Guntuku; X S Cui; S Matsuoka; D Cortez; K Tamai; G Luo; S Carattini-Rivera; F DeMayo; A Bradley; L A Donehower; S J Elledge
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

Review 4.  G2 checkpoint abrogators as anticancer drugs.

Authors:  Takumi Kawabe
Journal:  Mol Cancer Ther       Date:  2004-04       Impact factor: 6.261

5.  Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer.

Authors:  Jide Wang; Qing Gu; Ming Li; Wenjing Zhang; Mo Yang; Bing Zou; Shing Chan; Liang Qiao; Bo Jiang; Shuiping Tu; Juan Ma; Ivan F Hung; Hui Yao Lan; Benjamin C Y Wong
Journal:  Carcinogenesis       Date:  2009-07-23       Impact factor: 4.944

6.  DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress.

Authors:  Van Leung-Pineda; Jiwon Huh; Helen Piwnica-Worms
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

7.  Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control.

Authors:  Deborah Wilsker; Eva Petermann; Thomas Helleday; Fred Bunz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-17       Impact factor: 11.205

8.  Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

Authors:  Y E Chin; M Kitagawa; W C Su; Z H You; Y Iwamoto; X Y Fu
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

Review 9.  Interferons, interferon-like cytokines, and their receptors.

Authors:  Sidney Pestka; Christopher D Krause; Mark R Walter
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

10.  Regulation of chk1.

Authors:  Claudia Tapia-Alveal; Teresa M Calonge; Matthew J O'Connell
Journal:  Cell Div       Date:  2009-04-29       Impact factor: 5.130

View more
  6 in total

Review 1.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

2.  Enhancement of cellular radiation sensitivity through degradation of Chk1 by the XIAP-XAF1 complex.

Authors:  Kwang Seok Kim; Jong-Ik Heo; Kyu Jin Choi; Sangwoo Bae
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

3.  Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice.

Authors:  Yan-Yang Wang; Cui-Ying Zhang; Ya-Qiong Ma; Zhi-Xu He; Hong Zhe; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-06-22       Impact factor: 4.162

4.  Ameliorating effects of Gö6976, a pharmacological agent that inhibits protein kinase D, on collagen-induced arthritis.

Authors:  Tae Won Yoon; Young-In Kim; Hongsik Cho; David D Brand; Edward F Rosloniec; Linda K Myers; Arnold E Postlethwaite; Karen A Hasty; John M Stuart; Ae-Kyung Yi
Journal:  PLoS One       Date:  2019-12-06       Impact factor: 3.240

5.  Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.

Authors:  Laura Timares; Craig A Elmets; Tahseen H Nasti; Nabiha Yusuf; Mohammad Asif Sherwani; Mohammad Athar
Journal:  Cancer Prev Res (Phila)       Date:  2020-11-04

6.  XIAP-associating factor 1, a transcriptional target of BRD7, contributes to endothelial cell senescence.

Authors:  Jong-Ik Heo; Wonwoo Kim; Kyu Jin Choi; Sangwoo Bae; Jae-Hoon Jeong; Kwang Seok Kim
Journal:  Oncotarget       Date:  2016-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.